Estrogen Replacement Therapy Market Trends

  • Report ID: 2374
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Estrogen Replacement Therapy Market Trends

Growth Drivers

Relief from Menopausal Symptoms to Raise the Demand for Estrogen Therapy

According to a report published by the Centers for Disease Control and Prevention in 2017, around 27.1% of postmenopausal women between the ages 40 and 59 were highly likely to have trouble falling asleep as compared with premenopausal women. Moreover, about 55.1% of postmenopausal women aged between 40 and 59 were more likely than premenopausal women to wake up not feeling well rested for at least 4 days per week. Growing awareness among women about the serious implications of menopause which can lead to disorders and discomfort and affect their daily lives has resulted in the increasing adoption of hormone therapies such as estrogen replacement therapy by women. This is anticipated to lead to substantial market growth during the forecast period. 

Availability of Various Types of Therapies to Drive the Market Growth

The rising population of post-menopausal women is attributed to the growing demand for improved estrogen replacement therapies with better efficacy and lesser side-effects. Further, the benefits of estrogen therapy in improving health conditions such as osteoporosis are estimated to increase the demand in near future. On account of these factors, the market growth is anticipated to witness a notable hike over the forecast period.

Challenges

Side-Effects Linked with the Use of Estrogen Therapy to Restrict the Market Growth

Medications containing hormones show certain side-effects which might be either mild or serious. Moreover, estrogen replacement therapy cannot be used in case women have the conditions such as liver problems, bleeding disorder, pregnancy, severe reactions to estrogen medicines among other health conditions. This is estimated to hamper the market growth in the next few years.

Estrogen Replacement Therapy Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2374
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising awareness among women about the serious implications of menopause which can lead to disorders and discomfort is a major growth factor for the market growth.

The market is anticipated to attain a significant CAGR over the forecast period, i.e. 2020-2028.

The market in Europe is anticipated to provide increased business opportunities as a result of growing technological advancements in the healthcare industry.

The major players in the market are Abbott Laboratories, Pfizer Inc., Novartis, Bayer Healthcare, Eli Lilly, Novo Nordisk, Merck, Allergan, Orion Pharma and TherapeuticsMD, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample